FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/073911 [Registered on: 13/09/2024] Trial Registered Prospectively
Last Modified On: 08/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [EPISIOTOMY SUTURE MATERIALS]  
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   A clinical trial on three suture materials (Chromic catgut, Polyglactin 910, Polyglactin 910 Rapide) used in Episiotomy suturing and its outcomes. 
Scientific Title of Study   Outcomes of Episiotomy suturing using Chromic Catgut, Polyglactin 910,Polyglactin 910 Rapide sutures- A Triple – arm, Concurrent parallel Randomised Controlled Trial. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  NANDINI S 
Designation  JUNIOR RESIDENT 
Affiliation  AARUPADAI VEEDU MEDICAL COLLEGE,PONDICHERRY 
Address  Department of Obstetrics and Gynecology, A block, NO 22, Aarupadai veedu medical college and hospital, Puducherry Cuddalore main road,Kirumampakkam, Pondicherry

Pondicherry
PONDICHERRY
607403
India 
Phone  9842304256  
Fax    
Email  nandinisenthilkumar25@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  SASIKALA R 
Designation  PROFESSOR 
Affiliation  AARUPADAI VEEDU MEDICAL COLLEGE,PONDICHERRY 
Address  DEPARTMENT OF OBSTETRICS AND GYNECOLOGY,A BLOCK,NO 22,AARUPADAI VEEDU MEDICAL COLLEGE,PUDUCHERRY CUDDALORE MAIN ROAD,KIRUMAMPAKKAM,PONDICHERRY

Pondicherry
PONDICHERRY
607403
India 
Phone  9443176240  
Fax    
Email  kalapani1955@gmail.com  
 
Details of Contact Person
Public Query
 
Name  NANDINI S 
Designation  JUNIOR RESIDENT 
Affiliation  AARUPADAI VEEDU MEDICAL COLLEGE,PONDICHERRY 
Address  DEPARTMENT OF OBSTETRICS AND GYNECOLOGY,A BLOCK,NO 22,AARUPADAI VEEDU MEDICAL COLLEGE,PONDICHERRY CUDDALORE MAIN ROAD,KIRUMAMPAKKAM,PONDICHERRY

Pondicherry
PONDICHERRY
607403
India 
Phone  9842304256  
Fax    
Email  nandinisenthilkumar25@gmail.com  
 
Source of Monetary or Material Support  
AARUPADAI VEEDU MEDICAL COLLEGE AND HOSPITAL,PONDICHERRY CUDDALORE MAIN ROAD,KIRUMAMPAKKAM,PONDICHERRY 607402 
 
Primary Sponsor  
Name  AARUPADAI VEEDU MEDICAL COLLEGE AND HOSPITAL 
Address  DEPARTMENT OF OBSTETRICS AND GYNECOLOGY,A BLOCK,NO 22,AARUPADAI VEEDU MEDICAL COLLEGE,PONDICHERRY CUDDALORE MAIN ROAD,KIRUMAMPAKKAM,PONDICHERRY 607402 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
NANDINI S  AARUPADAI VEEDU MEDICAL COLLEGE AND HOSPITAL  DEPARTMENT OF OBSTETRICS AND GYNECOLOGY,NO22,AARUPADAI VEEDU MEDICAL COLLEGE AND HOSPITAL,PONDICHERRY CUDDALORE MAIN ROAD,KIRUMAMPAKKAM,PONDICHERRY 607402
Pondicherry
PONDICHERRY 
9842304256

nandinisenthilkumar25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL HUMAN ETHICAL COMMITTE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O901||Disruption of perineal obstetric wound,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  CHROMIC CATGUT  TENSILE STRENGTH IS 28 DAYS AND NO OF DAYS TAKEN FOR ABSORPTION IS 90 DAYS 
Intervention  POLYGLACTIN 910   TENSILE STRENGTH IS 4-5WEEKS AND NO OF DAYS TAKEN FOR ABSORPTION IS 56-70 DAYS 
Intervention  POLYGLACTIN 910 RAPIDE  TENSILE STRENGTH IS 10-14 DAYS AND NO OF DAYS TAKEN FOR ABSORPTION IS 42 DAYS 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  ALL VAGINAL DELIVERIES UNDERGOING EPISIOTOMY 
 
ExclusionCriteria 
Details  INFECTION (CHORIOAMNIONITIS) 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the effectiveness of three absorbable suture materials - Chromic Catgut, Polyglactin 910,Polyglactin 910 Rapide sutures in terms of postoperative outcomes  Day 1,Day 2,Day 3,2ND week,4TH week,3 months postnatally 
 
Secondary Outcome  
Outcome  TimePoints 
POSTOPERATIVE PAIN,WOUND HEALING,SCARRING/FIBROSIS  DAY1,DAY2,DAY3,2ND WEEK,4TH WEEK,3MONTHS POSTNATALLY 
 
Target Sample Size   Total Sample Size="78"
Sample Size from India="78" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   After getting IEC clearance from the institute and CTRI registration, informed and written consent from the patient who are willing to get enrolled in the study. Patients undergoing vaginal deliveries will be taken up for study based on inclusion and exclusion criteria. Patients having vaginal delivery with mediolateral episiotomy will be randomly allocated into 3 groups. Block randomization sequential allocation into blocks. Random sequence generation by random table prior to start of study. Group A (CHROMIC CATGUT), Group B (POLYGLACTIN 910), Group C (POLYGLACTIN 910 RAPIDE). All patients are sutured by same technique and by the same person. Same postoperative antibiotic and analgesic were given to all patients. Postoperative outcomes such as pain, healing, scarring/dyspareunia followed up on Day1,Day 2, Day 3,2nd week,4th week and 3 months postnatally. 
Close